These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32129215)

  • 1. Cost implication of inpatient care of chronic kidney disease patients in a tertiary hospital in Southwest Nigeria.
    Adejumo OA; Akinbodewa AA; Ogunleye A; Enikuomehin AC; Lawal OM
    Saudi J Kidney Dis Transpl; 2020; 31(1):209-214. PubMed ID: 32129215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.
    van Oosten MJM; Logtenberg SJJ; Leegte MJH; Bilo HJG; Mohnen SM; Hakkaart-van Roijen L; Hemmelder MH; de Wit GA; Jager KJ; Stel VS
    Nephrol Dial Transplant; 2020 Dec; 35(12):2138-2146. PubMed ID: 31598728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study.
    Chen B; Fan VY; Chou YJ; Kuo CC
    BMC Nephrol; 2017 Jan; 18(1):36. PubMed ID: 28122500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.
    Anutrakulchai S; Mairiang P; Pongskul C; Thepsuthammarat K; Chan-On C; Thinkhamrop B
    BMC Health Serv Res; 2016 Sep; 16(1):528. PubMed ID: 27686066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease in children as seen in a tertiary hospital in Enugu, South-East, Nigeria.
    Odetunde OI; Okafor HU; Uwaezuoke SN; Ezeonwu BU; Adiele KD; Ukoha OM
    Niger J Clin Pract; 2014; 17(2):196-200. PubMed ID: 24553031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
    Chen W; Howard K; Gorham G; Abeyaratne A; Zhao Y; Adegboye O; Kangaharan N; Talukder MRR; Taylor S; Cass A;
    BMC Health Serv Res; 2024 Jul; 24(1):791. PubMed ID: 38982437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs.
    Kerr M; Matthews B; Medcalf JF; O'Donoghue D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1504-1509. PubMed ID: 27207901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic impact of kidney patients with sepsis in hospital setting].
    Battaglia Y; Guerzoni F; Gigante M; Veronesi M; Oppi C; Forini E; Ullo I; Vagnoni E; Storari A
    G Ital Nefrol; 2019 Dec; 36(6):. PubMed ID: 31830394
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative outcomes of coronary artery bypass graft in renal transplant recipients in the United States: results from the Nationwide Inpatient Sample.
    Tooley JE; Bohl DD; Kulkarni S; Rodriguez-Davalos MI; Mangi A; Mulligan DC; Yoo PS
    Clin Transplant; 2016 Oct; 30(10):1258-1263. PubMed ID: 27440000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives.
    Aoun M; Helou E; Sleilaty G; Zeenny RM; Chelala D
    BMC Health Serv Res; 2022 May; 22(1):586. PubMed ID: 35501814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of patients with chronic kidney disease in Germany.
    Gandjour A; Armsen W; Wehmeyer W; Multmeier J; Tschulena U
    PLoS One; 2020; 15(4):e0231375. PubMed ID: 32330140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    Goncalves GMR; Silva END
    PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of chronic kidney disease in Korea using national sample cohort.
    Kim SH; Jo MW; Go DS; Ryu DR; Park J
    J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.